Abstract:As the global population ages at an unprecedented rate, the prevalence of age-related diseases is increasing, making inflammaging - a phenomenon characterized by a chronic, low-grade inflammatory state that follows aging - a significant concern. Understanding the mechanisms of inflammaging and its impact on health is critical for developing strategies to improve the quality of life and manage health in the aging population. Despite their crucial roles in various biological processes, including immune response modulation, N-glycans, oligosaccharides covalently attached to many proteins, are often overlooked in clinical and research studies. This repeated oversight is largely due to their inherent complexity and the complexity of the analysis methods. High-throughput N-glycan analysis has emerged as a transformative tool in N-glycosylation research, enabling cost- and time-effective, detailed, and large-scale examination of N-glycan profiles. This paper is the first to explore the application of high-throughput N-glycomics techniques to investigate the complex interplay between N-glycosylation and the immune system in aging. Technological advancements have significantly improved Nglycan detection and characterization, providing insights into age-related changes in Nglycosylation. Key findings highlight consistent shifts in immunoglobulin G (IgG) and plasma/serum glycoprotein glycosylation with age, with a pronounced rise in agalactosylated structures bound to IgG that also affect the composition of the total plasma N-glycome. These N-glycan modifications seem to be strongly associated with inflammaging and have been identified as valuable biomarkers for biological age, predictors of disease risk, and proxy biomarkers for monitoring intervention efficacy at the individual level. Despite current challenges related to data complexity and methodological limitations, ongoing technological innovations and interdisciplinary research are expected tofurther advance our knowledge of glycan biology, improve diagnostic and therapeutic strategies, and promote healthier aging. The integration of glycomics with other omics approaches holds promise for a more comprehensive understanding of the aging immune system, paving the way for personalized medicine and targeted interventions to mitigate inflammaging. In conclusion, this paper underscores the transformative impact of high-throughput Nglycan analysis in aging and inflammaging.

Glycans are a novel biomarker of chronological and biological ages

Glycan clock of ageing—analytical precision and time-dependent inter- and i-individual variability

Mapping of the gene network that regulates glycan clock of ageing

N-glycomic biomarkers of biological aging and longevity: a link with inflammaging

Global Variability of the Human IgG Glycome

High-throughput N-glycan analysis in aging and inflammaging: State of the art and future directions

Absolute Quantification of Aging-Associated Glycans in IgG for Biological Age Prediction: Insights from Glycomics and Transcriptomics

Profiling of IgG N-glycome During Mouse Aging: Fucosylated Diantennary Glycans Containing One Neu5Gc-linked LacNAc Are Associated with Age

Immunoglobulin G glycosylation and its alterations in aging-related diseases

Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity

The Causality Between Human Immunoglobulin G (igg) N-Glycosylation and Aging: A Mendelian Randomization Study

IgG N-Glycosylation Cardiovascular Age Tracks Cardiovascular Risk Beyond Calendar Age

The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals

Effects of testosterone and metformin on the GlycanAge index of biological age and the composition of the IgG glycome

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease

N-Glycan profiling in the study of human aging

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia

Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases

A Rapidly Aging World in the 21st Century: Hopes from Glycomics and Unraveling the Biomarkers of Aging with the Sugar Code

Systematic Review: Immunoglobulin G N-Glycans As Next-Generation Diagnostic Biomarkers for Common Chronic Diseases